- Home
- OLMA vs MCR Comparison
OLMA vs MCR Comparison
Compare OLMA & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- MCR
- Stock Information
- Founded
- OLMA 2006
- MCR 1989
- Country
- OLMA United States
- MCR United States
- Employees
- OLMA N/A
- MCR N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- MCR Trusts Except Educational Religious and Charitable
- Sector
- OLMA Health Care
- MCR Finance
- Exchange
- OLMA Nasdaq
- MCR Nasdaq
- Market Cap
- OLMA 289.0M
- MCR 250.1M
- IPO Year
- OLMA 2020
- MCR N/A
- Fundamental
- Price
- OLMA $5.28
- MCR $6.29
- Analyst Decision
- OLMA Strong Buy
- MCR
- Analyst Count
- OLMA 4
- MCR 0
- Target Price
- OLMA $24.50
- MCR N/A
- AVG Volume (30 Days)
- OLMA 688.0K
- MCR 66.7K
- Earning Date
- OLMA 05-13-2025
- MCR 01-01-0001
- Dividend Yield
- OLMA N/A
- MCR 8.52%
- EPS Growth
- OLMA N/A
- MCR N/A
- EPS
- OLMA N/A
- MCR 0.38
- Revenue
- OLMA N/A
- MCR N/A
- Revenue This Year
- OLMA N/A
- MCR N/A
- Revenue Next Year
- OLMA N/A
- MCR N/A
- P/E Ratio
- OLMA N/A
- MCR $16.61
- Revenue Growth
- OLMA N/A
- MCR N/A
- 52 Week Low
- OLMA $2.86
- MCR $5.63
- 52 Week High
- OLMA $16.62
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- OLMA 60.00
- MCR 58.06
- Support Level
- OLMA $4.80
- MCR $6.19
- Resistance Level
- OLMA $5.61
- MCR $6.31
- Average True Range (ATR)
- OLMA 0.38
- MCR 0.07
- MACD
- OLMA 0.02
- MCR 0.00
- Stochastic Oscillator
- OLMA 78.71
- MCR 52.63
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.